G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,529,500 | -67.0% | 650,000 | -24.1% | 0.92% | -63.9% |
| Q3 2022 | $10,701,000 | +152.8% | 856,798 | 0.0% | 2.53% | +115.5% |
| Q2 2022 | $4,233,000 | -35.0% | 856,798 | 0.0% | 1.18% | -32.7% |
| Q1 2022 | $6,512,000 | -25.6% | 856,798 | 0.0% | 1.75% | +9.6% |
| Q4 2021 | $8,748,000 | -24.2% | 856,798 | -0.4% | 1.60% | -10.9% |
| Q3 2021 | $11,548,000 | -35.2% | 860,502 | +5.9% | 1.79% | -38.9% |
| Q2 2021 | $17,833,000 | -20.1% | 812,794 | -12.4% | 2.93% | +4.5% |
| Q1 2021 | $22,323,000 | -56.4% | 927,794 | -67.4% | 2.80% | -36.6% |
| Q4 2020 | $51,228,000 | +211.5% | 2,847,588 | +100.0% | 4.42% | +11.7% |
| Q3 2020 | $16,445,000 | -52.4% | 1,423,794 | 0.0% | 3.96% | -56.9% |
| Q2 2020 | $34,541,000 | +120.1% | 1,423,794 | 0.0% | 9.18% | -4.2% |
| Q1 2020 | $15,690,000 | -58.3% | 1,423,794 | 0.0% | 9.58% | -28.1% |
| Q4 2019 | $37,631,000 | – | 1,423,794 | – | 13.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 120,000 | $172,800 | 0.15% |
| DENALI ADVISORS LLC | 148,800 | $214,272 | 0.08% |
| XTX Topco Ltd | 296,601 | $427,105 | 0.07% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 234,000 | $336,960 | 0.06% |
| LEVEL FOUR ADVISORY SERVICES, LLC | 183,400 | $264,096 | 0.02% |
| Curi Wealth Management, LLC | 70,742 | $101,869 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 83,400 | $120 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 140,000 | $201,600 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 573,256 | $825,489 | 0.01% |
| ALGERT GLOBAL LLC | 68,100 | $98 | 0.01% |